跳至主要内容
临床试验/KCT0008395
KCT0008395招募中Unknown

Evaluation of the safety and usefulness of 5-FU local injection for the treatment of advanced gastric cancer

Kangbuk Samsung Medical Center0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients aged 18 years or older with histologically confirmed adenocarcinoma and diagnosed with advanced gastric cancer that is not amenable to radical resection at the time of diagnosis who meet the following conditions are eligible.
  • Patients who have failed standard treatment or for whom standard treatment is not feasible,
  • Patients with measurable lesions in the stomach on endoscopy,
  • Patients with a predicted survival time of 3 months or more.

排除标准

  • ?Patients with a history of cancer other than gastric cancer
  • ?Patients who do not consent to this treatment
  • ?Nursing mothers other than pregnant women or women of childbearing potential who are planning to become pregnant
  • ?Patients receiving Tegapur-Gimeracil-Oterasil potassium combination and patients who have stopped taking it within 7 days.
  • ?Patients receiving sorbudine
  • ?Patients with a history of severe hypersensitivity to 5-FU
  • ?Patients with bone marrow depression after treatment with other antineoplastic agents, radiation therapy, or extreme frailty
  • ?Patients with non-malignant tumor disease

研究者

相似试验